yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.

2008 West
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
Red Hat
The Opening of Virtualization
User Environment Management – The Third Layer of the Desktop
Cloud Computing for Business Agility
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Return on Assests: Bringing Visibility to your SOA Strategy
Managing Hybrid Endpoint Environments
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
How Can AJAX Improve Homeland Security?
Beyond Widgets: What a RIA Platform Should Offer
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
Today's Top SOA Links

Breaking News In Prostate Cancer Diagnoses
The PCA3 urine test and a new image-guided prostate biopsy may revolutionize prostate cancer diagnosis and treatment, says robotic prostate surgeon, David Samadi, MD.

NEW YORK, Dec. 14, 2012 /PRNewswire/ -- Despite the volume of prostate cancer tests and treatments, experts and their patients are continually challenged to predict the disease's course and apply the most appropriate treatment. Now, two new diagnostic innovations – the PCA3 urine test and a more targeted prostate biopsy technique - could refine the way doctors diagnose prostate cancer and, subsequently, the way patients elect to treat it.

(Photo: )

Current prostate cancer tests yield limited results. The prostate-specific antigen (PSA) blood test indicates the potential presence of prostate cancer, but it cannot predict disease type or aggression. The prostate biopsy confirms a prostate cancer diagnosis, but tissue retrieval is challenged by prostate gland size and placement and can result in missed tumors. Prostate cancer treatment expert, Dr. David Samadi, relies on both exams prior to recommending and performing his Samadi Modified Advanced Robotic Technique (SMART) prostate removal surgery, but agrees that testing could be enhanced. "Prostate cancer innovations like these will continually improve the life-saving benefits of early diagnosis and intervention," said Dr. Samadi.

What is PCA3?
PCA3, prostate cancer gene 3, is a gene-based urine test believed to more accurately predict the presence of prostate cancer and its future course. Unlike PSA level, PCA3 is not affected by other prostate conditions, such as benign prostatic hyperplasia (BPH), so results are more reliable.

"There are two viable applications for PCA3 scoring," explained Dr. Samadi. "If we learn that a man's PCA3 is elevated before biopsy, we can proceed with greater certainty of the biopsy's necessity. After biopsy, the test could help assess the urgency with which we treat the disease. Both applications could give greater peace of mind to men weighing treatment options, particularly robotic prostate removal surgery," he said.

More Targeted Prostate Biopsy
Researchers at the University of California Los Angeles (UCLA) published findings of an image-guided prostate biopsy study in this month's Journal of Urology, Attempting to produce more accurate biopsy results, they combined the imaging capabilities of MRI with ultrasound. Using this new prostate map, the biopsies performed under their study yielded a positive prostate cancer diagnosis in 53 percent of the 171 participants.

"Prostate biopsies can yield uncertain results," explains Dr. Samadi. "But using enhanced, overlaid imaging to more accurately collect prostate tissue is very similar to the robotically-enhanced visibility used during robotic surgery. This new, targeted approach mirrors the refinements afforded by the robot and could yield equally positive results."

David Samadi is Vice Chairman, Department of Urology and Chief of Robotics and Minimally Invasive Surgery at New York's Mount Sinai Medical Center where he has performed more than 4,000 successful SMART prostate removals.

Related Links:

Related Videos:

SMART Robotic Prostate Surgery - David Samadi, MD

PSA Test: Prostate Screening Saves Lives

PROSTATE CANCER NEWS - Prostate Surgery Takes a Team



About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Web 2.0 Latest News
Ten short years ago, Apache Hadoop was just a small project deployed on a few machines at Yahoo and within a few years, it had truly become the backbone of Yahoo’s data infrastructure. Additionally, the current Apache Hadoop market is forecasted to surpass $16 billion by 2020. This mi...
Last week, I was a keynote speaker at the Mobile Edge '16 conference in Lisbon, Portugal. Following the conference I met individually with many different companies. These companies represented a variety of industries, sizes and digital maturity levels. I was sharing my latest digital ...
When we talk about the impact of BYOD and BYOA and the Internet of Things, we often focus on the impact on data center architectures. That's because there will be an increasing need for authentication, for access control, for security, for application delivery as the number of potentia...
My favorite writer, Gil Press, sums it up with, “It’s Official: The Internet Of Things Takes Over Big Data As The Most Hyped Technology” where he talks about how Gartner released its latest Hype Cycle for Emerging Technologies, and how big data has moved down the “trough of disillusion...
COMED, my power company, sends out a monthly report that shows me my energy consumption relative to my neighbors. Every month I’m considerably higher than all my neighbors. This report also has a list of things I could do to reduce my energy consumption. The problem with this report is...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)!

Advertise on this site! Contact advertising(at)! 201 802-3021

SYS-CON Featured Whitepapers